Integer Holdings Co. (NYSE:ITGR) to Post Q1 2024 Earnings of $1.11 Per Share, Zacks Research Forecasts

Integer Holdings Co. (NYSE:ITGR) – Analysts at Zacks Research dropped their Q1 2024 EPS estimates for Integer in a research report issued to clients and investors on Thursday, April 18th. Zacks Research analyst D. Dey now forecasts that the medical equipment provider will post earnings per share of $1.11 for the quarter, down from their prior estimate of $1.14. The consensus estimate for Integer’s current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Integer’s Q3 2024 earnings at $1.40 EPS, Q4 2024 earnings at $1.52 EPS, FY2024 earnings at $5.25 EPS, Q3 2025 earnings at $1.58 EPS, FY2025 earnings at $6.08 EPS and FY2026 earnings at $6.51 EPS.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, February 15th. The medical equipment provider reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.34 by $0.05. The business had revenue of $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. Integer had a return on equity of 10.80% and a net margin of 5.68%. The firm’s revenue was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.11 earnings per share.

A number of other equities analysts have also recently weighed in on the stock. CL King began coverage on shares of Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 price target on the stock. Bank of America raised Integer from a “neutral” rating to a “buy” rating and boosted their target price for the company from $105.00 to $135.00 in a research note on Monday, April 15th. KeyCorp increased their price target on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Finally, Benchmark lifted their price objective on Integer from $105.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, March 28th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $120.50.

Integer Stock Down 1.1 %

Integer stock opened at $116.58 on Friday. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of 43.34, a PEG ratio of 1.64 and a beta of 1.10. The company’s 50 day simple moving average is $111.82 and its 200 day simple moving average is $98.49. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.80 and a quick ratio of 1.71. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $121.53.

Hedge Funds Weigh In On Integer

A number of large investors have recently modified their holdings of ITGR. Covestor Ltd increased its holdings in Integer by 420.6% during the first quarter. Covestor Ltd now owns 328 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 265 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 377 shares during the period. State of Wyoming raised its holdings in shares of Integer by 129.5% in the 4th quarter. State of Wyoming now owns 840 shares of the medical equipment provider’s stock valued at $58,000 after purchasing an additional 474 shares during the period. Tower Research Capital LLC TRC grew its holdings in Integer by 28.5% during the first quarter. Tower Research Capital LLC TRC now owns 775 shares of the medical equipment provider’s stock worth $60,000 after purchasing an additional 172 shares during the period. Finally, Principal Securities Inc. acquired a new position in Integer during the fourth quarter worth approximately $67,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.